PRESCRIBING · PART D · 2024
Total Rx claims
201
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
8
Brand share
38.3%
Top prescribed drugs
Ustekinumab51 claims
Omeprazole33 claims
Ciprofloxacin Hcl26 claims
Sulfasalazine26 claims
Mesalamine20 claims
QUALITY · MIPS · 2024
Final MIPS score
89.8
Quality
91.5
Cost
74.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.62%
Group
CROSS-REFERENCE